Varaico: Literature-Extracted Genetic Variants

Gene:NAGLU
Variant:p.R234C
Back to variants list

NAGLU

NM_000263.4:p.R234C

Associated Papers

Whole-Exome sequencing and systems biology approaches revealed pathogenicity of compound heterozygote variants of NAGLU gene manifesting developmental regression, brain atrophy, intellectual disability, and ADHD.

Moeinifar N et al.

Molecular Biology Reports, 2025

Disease progression in Sanfilippo type B: Case series of Brazilian patients.

Montenegro YHA et al.

Genetics and Molecular Biology, 2024

Germline mutations and developmental mosaicism underlying EGFR-mutant lung cancer.

Burr R et al.

Medrxiv : the Preprint Server for Health Sciences, 2023

37808694 (PubMed )
Supplement: media-2.xlsx › Patient_9

Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment.

Jiang Y et al.

Nature Communications, 2022

36418292 (PubMed )
Supplement: 41467_2022_34689_MOESM4_ESM.zip › Supplementary_Data › Supplementary_Data_5.xlsx › Sheet1

Longitudinal Natural History of Pediatric Subjects Affected with Mucopolysaccharidosis IIIB.

Okur I et al.

The Journal of Pediatrics, 2022

Unusual Clinical Manifestations in a Mexican Patient with Sanfilippo B Syndrome.

Fernández-Hernández L et al.

Diagnostics (basel, Switzerland), 2022

Sanfilippo syndrome type B: Analysis of patients diagnosed by the MPS Brazil Network.

Montenegro YHA et al.

American Journal of Medical Genetics. Part A, 2022

Mucopolysaccharidosis III in Taiwan: Natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21-year period.

Lin HY et al.

American Journal of Medical Genetics. Part A, 2018

Utilizing ExAC to assess the hidden contribution of variants of unknown significance to Sanfilippo Type B incidence.

Clark WT et al.

Plos One, 2018

29979746 (PubMed )
Supplement: pone.0200008.s004.xlsx › Sheet1

Epidemiology of mucopolysaccharidoses.

Khan SA et al.

Molecular Genetics and Metabolism, 2017

Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons.

Matalonga L et al.

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics, 2015

Assessment of a targeted resequencing assay as a support tool in the diagnosis of lysosomal storage disorders.

Fernández-Marmiesse A et al.

Orphanet Journal of Rare Diseases, 2014

Mucopolysaccharidosis type IIIB mutations in Chinese patients: identification of two novel NAGLU mutations and analysis of two cases involving prenatal diagnosis.

Tang J et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry, 2013

Molecular analysis of mucopolysaccharidosis type IIIB in Portugal: evidence of a single origin for a common mutation (R234C) in the Iberian Peninsula.

Mangas M et al.

Clinical Genetics, 2008

Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.

Yogalingam G et al.

Human Mutation, 2001

Allelic heterogeneity in Spanish patients with Sanfilippo disease type B. Identification of eight new mutations.

Coll MJ et al.

Journal of Inherited Metabolic Disease, 2001

Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB).

Beesley CE et al.

Journal of Medical Genetics, 1998

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."